nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—UGT1A1—Etoposide—urinary bladder cancer	0.169	1	CbGbCtD
Abacavir—ADH6—renal system—urinary bladder cancer	0.0346	0.233	CbGeAlD
Abacavir—UGT1A1—urine—urinary bladder cancer	0.0323	0.218	CbGeAlD
Abacavir—UGT1A1—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.0195	0.0729	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.018	0.0672	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTZ1—urinary bladder cancer	0.0122	0.0457	CbGpPWpGaD
Abacavir—ADK—prostate gland—urinary bladder cancer	0.0118	0.0793	CbGeAlD
Abacavir—UGT1A1—prostate gland—urinary bladder cancer	0.0116	0.0782	CbGeAlD
Abacavir—ADH6—Biological oxidations—GSTO2—urinary bladder cancer	0.0116	0.0433	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—NAT1—urinary bladder cancer	0.0116	0.0433	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—UGT2B7—urinary bladder cancer	0.0106	0.0396	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.0102	0.0381	CbGpPWpGaD
Abacavir—ADK—seminal vesicle—urinary bladder cancer	0.00995	0.0671	CbGeAlD
Abacavir—ADH6—Biological oxidations—CYP4B1—urinary bladder cancer	0.00954	0.0357	CbGpPWpGaD
Abacavir—Cladribine—RRM2—urinary bladder cancer	0.00945	1	CrCbGaD
Abacavir—UGT1A1—Glucuronidation—UGT2B7—urinary bladder cancer	0.00936	0.035	CbGpPWpGaD
Abacavir—ADK—smooth muscle tissue—urinary bladder cancer	0.00833	0.0561	CbGeAlD
Abacavir—ADK—renal system—urinary bladder cancer	0.00802	0.054	CbGeAlD
Abacavir—UGT1A1—renal system—urinary bladder cancer	0.00791	0.0533	CbGeAlD
Abacavir—ADK—urethra—urinary bladder cancer	0.00788	0.0531	CbGeAlD
Abacavir—UGT1A1—Glucuronidation—UGT2B7—urinary bladder cancer	0.00759	0.0284	CbGpPWpGaD
Abacavir—ADK—Nucleotide metabolism—TYMP—urinary bladder cancer	0.00706	0.0264	CbGpPWpGaD
Abacavir—ADK—female reproductive system—urinary bladder cancer	0.00642	0.0433	CbGeAlD
Abacavir—ADH6—Biological oxidations—NAT2—urinary bladder cancer	0.00635	0.0237	CbGpPWpGaD
Abacavir—ADK—Purine metabolism—GPX1—urinary bladder cancer	0.00601	0.0225	CbGpPWpGaD
Abacavir—ADK—vagina—urinary bladder cancer	0.00581	0.0391	CbGeAlD
Abacavir—ADK—Nucleotide metabolism—RRM2—urinary bladder cancer	0.00551	0.0206	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—HPGDS—urinary bladder cancer	0.00508	0.019	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTT1—urinary bladder cancer	0.00492	0.0184	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—NQO1—urinary bladder cancer	0.00393	0.0147	CbGpPWpGaD
Abacavir—ADK—lymph node—urinary bladder cancer	0.00376	0.0253	CbGeAlD
Abacavir—ADH6—Biological oxidations—GSTP1—urinary bladder cancer	0.00341	0.0128	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTZ1—urinary bladder cancer	0.0033	0.0123	CbGpPWpGaD
Abacavir—ADK—Nucleotide metabolism—TYMS—urinary bladder cancer	0.00319	0.0119	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTM1—urinary bladder cancer	0.00314	0.0117	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTO2—urinary bladder cancer	0.00313	0.0117	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—NAT1—urinary bladder cancer	0.00313	0.0117	CbGpPWpGaD
Abacavir—ADK—Nucleotide metabolism—GPX1—urinary bladder cancer	0.00302	0.0113	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—GSTM1—urinary bladder cancer	0.00301	0.0113	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—UGT2B7—urinary bladder cancer	0.00286	0.0107	CbGpPWpGaD
Abacavir—UGT1A1—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.00283	0.0106	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTZ1—urinary bladder cancer	0.00209	0.00782	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTO2—urinary bladder cancer	0.00198	0.00741	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NAT1—urinary bladder cancer	0.00198	0.00741	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTZ1—urinary bladder cancer	0.00193	0.00722	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—UGT2B7—urinary bladder cancer	0.00191	0.00714	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.0019	0.00712	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.00186	0.00694	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTO2—urinary bladder cancer	0.00183	0.00685	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—NAT1—urinary bladder cancer	0.00183	0.00685	CbGpPWpGaD
Abacavir—ADH6—Metabolism—UGT2B7—urinary bladder cancer	0.00181	0.00678	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00181	0.00675	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—NAT2—urinary bladder cancer	0.00171	0.00641	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—UGT2B7—urinary bladder cancer	0.00167	0.00626	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00165	0.00618	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CYP4B1—urinary bladder cancer	0.00163	0.0061	CbGpPWpGaD
Abacavir—ADH6—Metabolism—SLC19A1—urinary bladder cancer	0.00154	0.00576	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—CYP4B1—urinary bladder cancer	0.00151	0.00564	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PRSS3—urinary bladder cancer	0.0015	0.00562	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00149	0.00556	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—HPGDS—urinary bladder cancer	0.00137	0.00513	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTT1—urinary bladder cancer	0.00133	0.00497	CbGpPWpGaD
Abacavir—ADH6—Metabolism—TYMP—urinary bladder cancer	0.0012	0.00449	CbGpPWpGaD
Abacavir—ADK—Metabolism—GSTZ1—urinary bladder cancer	0.00112	0.00417	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NAT2—urinary bladder cancer	0.00109	0.00406	CbGpPWpGaD
Abacavir—ADK—Metabolism—NAT1—urinary bladder cancer	0.00106	0.00396	CbGpPWpGaD
Abacavir—ADK—Metabolism—GSTO2—urinary bladder cancer	0.00106	0.00396	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—NAT2—urinary bladder cancer	0.001	0.00375	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000989	0.0037	CbGpPWpGaD
Abacavir—ADK—Metabolism—UGT2B7—urinary bladder cancer	0.000968	0.00362	CbGpPWpGaD
Abacavir—ADH6—Metabolism—RRM2—urinary bladder cancer	0.000937	0.0035	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTP1—urinary bladder cancer	0.000922	0.00345	CbGpPWpGaD
Abacavir—ADK—Metabolism—CYP4B1—urinary bladder cancer	0.000871	0.00326	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ENO2—urinary bladder cancer	0.000868	0.00325	CbGpPWpGaD
Abacavir—ADH6—Metabolism—HPGDS—urinary bladder cancer	0.000868	0.00325	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTM1—urinary bladder cancer	0.000847	0.00317	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTT1—urinary bladder cancer	0.000842	0.00315	CbGpPWpGaD
Abacavir—ADK—Metabolism—SLC19A1—urinary bladder cancer	0.000823	0.00308	CbGpPWpGaD
Abacavir—ADK—Metabolism—PRSS3—urinary bladder cancer	0.000802	0.003	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—HPGDS—urinary bladder cancer	0.000802	0.003	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTT1—urinary bladder cancer	0.000778	0.00291	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000744	0.00278	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—NQO1—urinary bladder cancer	0.000737	0.00276	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NQO1—urinary bladder cancer	0.0007	0.00262	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000667	0.00249	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000649	0.00243	CbGpPWpGaD
Abacavir—ADK—Metabolism—TYMP—urinary bladder cancer	0.000641	0.0024	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—GSTP1—urinary bladder cancer	0.000615	0.0023	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTP1—urinary bladder cancer	0.000584	0.00218	CbGpPWpGaD
Abacavir—ADK—Metabolism—NAT2—urinary bladder cancer	0.00058	0.00217	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000569	0.00213	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—GSTM1—urinary bladder cancer	0.000565	0.00211	CbGpPWpGaD
Abacavir—ADH6—Metabolism—TYMS—urinary bladder cancer	0.000543	0.00203	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000542	0.00203	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTP1—urinary bladder cancer	0.000539	0.00202	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTM1—urinary bladder cancer	0.000536	0.00201	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NCOR1—urinary bladder cancer	0.000536	0.00201	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000532	0.00199	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GPX1—urinary bladder cancer	0.000514	0.00192	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ERCC2—urinary bladder cancer	0.000504	0.00189	CbGpPWpGaD
Abacavir—ADK—Metabolism—RRM2—urinary bladder cancer	0.000501	0.00187	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTM1—urinary bladder cancer	0.000495	0.00185	CbGpPWpGaD
Abacavir—Skin disorder—Etoposide—urinary bladder cancer	0.000489	0.00121	CcSEcCtD
Abacavir—UGT1A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000489	0.00183	CbGpPWpGaD
Abacavir—Pancreatitis—Epirubicin—urinary bladder cancer	0.000487	0.0012	CcSEcCtD
Abacavir—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000486	0.0012	CcSEcCtD
Abacavir—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000485	0.0012	CcSEcCtD
Abacavir—Anorexia—Etoposide—urinary bladder cancer	0.00048	0.00118	CcSEcCtD
Abacavir—Diarrhoea—Thiotepa—urinary bladder cancer	0.00048	0.00118	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000478	0.00118	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000478	0.00118	CcSEcCtD
Abacavir—Decreased appetite—Cisplatin—urinary bladder cancer	0.000478	0.00118	CcSEcCtD
Abacavir—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000478	0.00118	CcSEcCtD
Abacavir—Bronchitis—Epirubicin—urinary bladder cancer	0.000477	0.00118	CcSEcCtD
Abacavir—Pneumonia—Methotrexate—urinary bladder cancer	0.000476	0.00117	CcSEcCtD
Abacavir—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000474	0.00117	CcSEcCtD
Abacavir—ADH6—Metabolism—MTHFR—urinary bladder cancer	0.000474	0.00177	CbGpPWpGaD
Abacavir—Depression—Methotrexate—urinary bladder cancer	0.000471	0.00116	CcSEcCtD
Abacavir—Hypotension—Etoposide—urinary bladder cancer	0.00047	0.00116	CcSEcCtD
Abacavir—Gastritis—Doxorubicin—urinary bladder cancer	0.00047	0.00116	CcSEcCtD
Abacavir—Pain—Cisplatin—urinary bladder cancer	0.00047	0.00116	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000469	0.00116	CcSEcCtD
Abacavir—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000469	0.00116	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000469	0.00116	CcSEcCtD
Abacavir—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000466	0.00115	CcSEcCtD
Abacavir—Renal failure—Methotrexate—urinary bladder cancer	0.000465	0.00115	CcSEcCtD
Abacavir—Neutropenia—Epirubicin—urinary bladder cancer	0.000464	0.00114	CcSEcCtD
Abacavir—ADK—Metabolism—ENO2—urinary bladder cancer	0.000464	0.00173	CbGpPWpGaD
Abacavir—ADK—Metabolism—HPGDS—urinary bladder cancer	0.000464	0.00173	CbGpPWpGaD
Abacavir—Dizziness—Thiotepa—urinary bladder cancer	0.000463	0.00114	CcSEcCtD
Abacavir—Stomatitis—Methotrexate—urinary bladder cancer	0.000461	0.00114	CcSEcCtD
Abacavir—Urticaria—Fluorouracil—urinary bladder cancer	0.000461	0.00114	CcSEcCtD
Abacavir—Conjunctivitis—Methotrexate—urinary bladder cancer	0.00046	0.00113	CcSEcCtD
Abacavir—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000458	0.00113	CcSEcCtD
Abacavir—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000453	0.00112	CcSEcCtD
Abacavir—Paraesthesia—Etoposide—urinary bladder cancer	0.000452	0.00111	CcSEcCtD
Abacavir—Pancreatitis—Doxorubicin—urinary bladder cancer	0.00045	0.00111	CcSEcCtD
Abacavir—ADK—Metabolism—GSTT1—urinary bladder cancer	0.00045	0.00168	CbGpPWpGaD
Abacavir—Dyspnoea—Etoposide—urinary bladder cancer	0.000449	0.00111	CcSEcCtD
Abacavir—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000448	0.0011	CcSEcCtD
Abacavir—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000447	0.0011	CcSEcCtD
Abacavir—Vomiting—Thiotepa—urinary bladder cancer	0.000446	0.0011	CcSEcCtD
Abacavir—Pneumonia—Epirubicin—urinary bladder cancer	0.000445	0.0011	CcSEcCtD
Abacavir—Rash—Thiotepa—urinary bladder cancer	0.000442	0.00109	CcSEcCtD
Abacavir—Bronchitis—Doxorubicin—urinary bladder cancer	0.000442	0.00109	CcSEcCtD
Abacavir—Dermatitis—Thiotepa—urinary bladder cancer	0.000442	0.00109	CcSEcCtD
Abacavir—Headache—Thiotepa—urinary bladder cancer	0.000439	0.00108	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000439	0.00108	CcSEcCtD
Abacavir—Decreased appetite—Etoposide—urinary bladder cancer	0.000438	0.00108	CcSEcCtD
Abacavir—Renal failure—Epirubicin—urinary bladder cancer	0.000435	0.00107	CcSEcCtD
Abacavir—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000435	0.00107	CcSEcCtD
Abacavir—Body temperature increased—Cisplatin—urinary bladder cancer	0.000434	0.00107	CcSEcCtD
Abacavir—Fatigue—Etoposide—urinary bladder cancer	0.000434	0.00107	CcSEcCtD
Abacavir—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000434	0.00107	CcSEcCtD
Abacavir—Stomatitis—Epirubicin—urinary bladder cancer	0.000431	0.00106	CcSEcCtD
Abacavir—Pain—Etoposide—urinary bladder cancer	0.000431	0.00106	CcSEcCtD
Abacavir—Conjunctivitis—Epirubicin—urinary bladder cancer	0.00043	0.00106	CcSEcCtD
Abacavir—Neutropenia—Doxorubicin—urinary bladder cancer	0.000429	0.00106	CcSEcCtD
Abacavir—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000427	0.00105	CcSEcCtD
Abacavir—Hepatitis—Methotrexate—urinary bladder cancer	0.000424	0.00105	CcSEcCtD
Abacavir—Asthenia—Gemcitabine—urinary bladder cancer	0.000423	0.00104	CcSEcCtD
Abacavir—Pharyngitis—Methotrexate—urinary bladder cancer	0.000421	0.00104	CcSEcCtD
Abacavir—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000419	0.00103	CcSEcCtD
Abacavir—Pruritus—Gemcitabine—urinary bladder cancer	0.000417	0.00103	CcSEcCtD
Abacavir—Nausea—Thiotepa—urinary bladder cancer	0.000416	0.00103	CcSEcCtD
Abacavir—Feeling abnormal—Etoposide—urinary bladder cancer	0.000415	0.00102	CcSEcCtD
Abacavir—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000414	0.00102	CcSEcCtD
Abacavir—Pneumonia—Doxorubicin—urinary bladder cancer	0.000412	0.00102	CcSEcCtD
Abacavir—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000412	0.00101	CcSEcCtD
Abacavir—Pruritus—Fluorouracil—urinary bladder cancer	0.00041	0.00101	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000406	0.001	CcSEcCtD
Abacavir—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000405	0.000998	CcSEcCtD
Abacavir—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000403	0.000995	CcSEcCtD
Abacavir—Renal failure—Doxorubicin—urinary bladder cancer	0.000402	0.000992	CcSEcCtD
Abacavir—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000401	0.000989	CcSEcCtD
Abacavir—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000401	0.000989	CcSEcCtD
Abacavir—Urticaria—Etoposide—urinary bladder cancer	0.0004	0.000986	CcSEcCtD
Abacavir—Stomatitis—Doxorubicin—urinary bladder cancer	0.000399	0.000984	CcSEcCtD
Abacavir—Body temperature increased—Etoposide—urinary bladder cancer	0.000398	0.000981	CcSEcCtD
Abacavir—Abdominal pain—Etoposide—urinary bladder cancer	0.000398	0.000981	CcSEcCtD
Abacavir—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000398	0.000981	CcSEcCtD
Abacavir—Hepatitis—Epirubicin—urinary bladder cancer	0.000397	0.000979	CcSEcCtD
Abacavir—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000397	0.000978	CcSEcCtD
Abacavir—Asthenia—Cisplatin—urinary bladder cancer	0.000394	0.000972	CcSEcCtD
Abacavir—Pharyngitis—Epirubicin—urinary bladder cancer	0.000394	0.000972	CcSEcCtD
Abacavir—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00039	0.000962	CcSEcCtD
Abacavir—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000387	0.000955	CcSEcCtD
Abacavir—ADH6—Metabolism—PPARG—urinary bladder cancer	0.000384	0.00144	CbGpPWpGaD
Abacavir—Immune system disorder—Methotrexate—urinary bladder cancer	0.000383	0.000945	CcSEcCtD
Abacavir—Dizziness—Fluorouracil—urinary bladder cancer	0.000383	0.000945	CcSEcCtD
Abacavir—Chills—Methotrexate—urinary bladder cancer	0.000381	0.000939	CcSEcCtD
Abacavir—Diarrhoea—Cisplatin—urinary bladder cancer	0.000376	0.000927	CcSEcCtD
Abacavir—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000376	0.000926	CcSEcCtD
Abacavir—Alopecia—Methotrexate—urinary bladder cancer	0.000375	0.000925	CcSEcCtD
Abacavir—Vomiting—Gemcitabine—urinary bladder cancer	0.000375	0.000924	CcSEcCtD
Abacavir—ADK—Metabolism—NQO1—urinary bladder cancer	0.000374	0.0014	CbGpPWpGaD
Abacavir—Rash—Gemcitabine—urinary bladder cancer	0.000372	0.000916	CcSEcCtD
Abacavir—Dermatitis—Gemcitabine—urinary bladder cancer	0.000371	0.000916	CcSEcCtD
Abacavir—Hypersensitivity—Etoposide—urinary bladder cancer	0.000371	0.000914	CcSEcCtD
Abacavir—Malnutrition—Methotrexate—urinary bladder cancer	0.00037	0.000911	CcSEcCtD
Abacavir—Headache—Gemcitabine—urinary bladder cancer	0.000369	0.000911	CcSEcCtD
Abacavir—ADH6—Metabolism—CREBBP—urinary bladder cancer	0.000369	0.00138	CbGpPWpGaD
Abacavir—Vomiting—Fluorouracil—urinary bladder cancer	0.000369	0.000909	CcSEcCtD
Abacavir—Hepatitis—Doxorubicin—urinary bladder cancer	0.000368	0.000906	CcSEcCtD
Abacavir—Rash—Fluorouracil—urinary bladder cancer	0.000366	0.000901	CcSEcCtD
Abacavir—Dermatitis—Fluorouracil—urinary bladder cancer	0.000365	0.0009	CcSEcCtD
Abacavir—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000365	0.000899	CcSEcCtD
Abacavir—Headache—Fluorouracil—urinary bladder cancer	0.000363	0.000895	CcSEcCtD
Abacavir—Asthenia—Etoposide—urinary bladder cancer	0.000361	0.000891	CcSEcCtD
Abacavir—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000361	0.00089	CcSEcCtD
Abacavir—Immune system disorder—Epirubicin—urinary bladder cancer	0.000359	0.000885	CcSEcCtD
Abacavir—Chills—Epirubicin—urinary bladder cancer	0.000356	0.000879	CcSEcCtD
Abacavir—Pruritus—Etoposide—urinary bladder cancer	0.000356	0.000878	CcSEcCtD
Abacavir—Alopecia—Epirubicin—urinary bladder cancer	0.000351	0.000865	CcSEcCtD
Abacavir—Nausea—Gemcitabine—urinary bladder cancer	0.00035	0.000863	CcSEcCtD
Abacavir—Vomiting—Cisplatin—urinary bladder cancer	0.000349	0.000861	CcSEcCtD
Abacavir—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000348	0.000857	CcSEcCtD
Abacavir—Rash—Cisplatin—urinary bladder cancer	0.000347	0.000854	CcSEcCtD
Abacavir—Dermatitis—Cisplatin—urinary bladder cancer	0.000346	0.000853	CcSEcCtD
Abacavir—Malnutrition—Epirubicin—urinary bladder cancer	0.000346	0.000852	CcSEcCtD
Abacavir—Diarrhoea—Etoposide—urinary bladder cancer	0.000344	0.000849	CcSEcCtD
Abacavir—Nausea—Fluorouracil—urinary bladder cancer	0.000344	0.000849	CcSEcCtD
Abacavir—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000343	0.000845	CcSEcCtD
Abacavir—Anaemia—Methotrexate—urinary bladder cancer	0.000342	0.000842	CcSEcCtD
Abacavir—Malaise—Methotrexate—urinary bladder cancer	0.000333	0.000821	CcSEcCtD
Abacavir—Dizziness—Etoposide—urinary bladder cancer	0.000333	0.000821	CcSEcCtD
Abacavir—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000332	0.000818	CcSEcCtD
Abacavir—Vertigo—Methotrexate—urinary bladder cancer	0.000332	0.000818	CcSEcCtD
Abacavir—Leukopenia—Methotrexate—urinary bladder cancer	0.000331	0.000815	CcSEcCtD
Abacavir—UGT1A1—Metabolism—GSTZ1—urinary bladder cancer	0.00033	0.00123	CbGpPWpGaD
Abacavir—Chills—Doxorubicin—urinary bladder cancer	0.00033	0.000813	CcSEcCtD
Abacavir—Nausea—Cisplatin—urinary bladder cancer	0.000326	0.000805	CcSEcCtD
Abacavir—Alopecia—Doxorubicin—urinary bladder cancer	0.000325	0.000801	CcSEcCtD
Abacavir—Cough—Methotrexate—urinary bladder cancer	0.000322	0.000795	CcSEcCtD
Abacavir—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000321	0.000791	CcSEcCtD
Abacavir—Convulsion—Methotrexate—urinary bladder cancer	0.00032	0.000789	CcSEcCtD
Abacavir—Vomiting—Etoposide—urinary bladder cancer	0.00032	0.000789	CcSEcCtD
Abacavir—Malnutrition—Doxorubicin—urinary bladder cancer	0.00032	0.000789	CcSEcCtD
Abacavir—Anaemia—Epirubicin—urinary bladder cancer	0.00032	0.000788	CcSEcCtD
Abacavir—Rash—Etoposide—urinary bladder cancer	0.000317	0.000783	CcSEcCtD
Abacavir—Dermatitis—Etoposide—urinary bladder cancer	0.000317	0.000782	CcSEcCtD
Abacavir—Headache—Etoposide—urinary bladder cancer	0.000315	0.000778	CcSEcCtD
Abacavir—Arthralgia—Methotrexate—urinary bladder cancer	0.000315	0.000776	CcSEcCtD
Abacavir—Myalgia—Methotrexate—urinary bladder cancer	0.000315	0.000776	CcSEcCtD
Abacavir—UGT1A1—Metabolism—GSTO2—urinary bladder cancer	0.000313	0.00117	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NAT1—urinary bladder cancer	0.000313	0.00117	CbGpPWpGaD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000312	0.00077	CcSEcCtD
Abacavir—Malaise—Epirubicin—urinary bladder cancer	0.000312	0.000769	CcSEcCtD
Abacavir—ADK—Metabolism—GSTP1—urinary bladder cancer	0.000312	0.00117	CbGpPWpGaD
Abacavir—Discomfort—Methotrexate—urinary bladder cancer	0.000311	0.000766	CcSEcCtD
Abacavir—Vertigo—Epirubicin—urinary bladder cancer	0.000311	0.000766	CcSEcCtD
Abacavir—Leukopenia—Epirubicin—urinary bladder cancer	0.00031	0.000763	CcSEcCtD
Abacavir—ADH6—Metabolism—PTGS2—urinary bladder cancer	0.000302	0.00113	CbGpPWpGaD
Abacavir—Cough—Epirubicin—urinary bladder cancer	0.000302	0.000744	CcSEcCtD
Abacavir—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000302	0.000743	CcSEcCtD
Abacavir—Convulsion—Epirubicin—urinary bladder cancer	0.0003	0.000739	CcSEcCtD
Abacavir—Infection—Methotrexate—urinary bladder cancer	0.0003	0.000739	CcSEcCtD
Abacavir—Nausea—Etoposide—urinary bladder cancer	0.000299	0.000737	CcSEcCtD
Abacavir—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000297	0.000732	CcSEcCtD
Abacavir—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000296	0.000729	CcSEcCtD
Abacavir—Anaemia—Doxorubicin—urinary bladder cancer	0.000296	0.000729	CcSEcCtD
Abacavir—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000295	0.000728	CcSEcCtD
Abacavir—Arthralgia—Epirubicin—urinary bladder cancer	0.000294	0.000726	CcSEcCtD
Abacavir—Myalgia—Epirubicin—urinary bladder cancer	0.000294	0.000726	CcSEcCtD
Abacavir—Anxiety—Epirubicin—urinary bladder cancer	0.000293	0.000723	CcSEcCtD
Abacavir—Skin disorder—Methotrexate—urinary bladder cancer	0.000293	0.000722	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000292	0.000721	CcSEcCtD
Abacavir—Discomfort—Epirubicin—urinary bladder cancer	0.000291	0.000717	CcSEcCtD
Abacavir—ADK—Metabolism—TYMS—urinary bladder cancer	0.00029	0.00108	CbGpPWpGaD
Abacavir—Malaise—Doxorubicin—urinary bladder cancer	0.000289	0.000711	CcSEcCtD
Abacavir—Vertigo—Doxorubicin—urinary bladder cancer	0.000287	0.000709	CcSEcCtD
Abacavir—Anorexia—Methotrexate—urinary bladder cancer	0.000287	0.000709	CcSEcCtD
Abacavir—Leukopenia—Doxorubicin—urinary bladder cancer	0.000286	0.000706	CcSEcCtD
Abacavir—ADK—Metabolism—GSTM1—urinary bladder cancer	0.000286	0.00107	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—UGT2B7—urinary bladder cancer	0.000286	0.00107	CbGpPWpGaD
Abacavir—ADK—Metabolism—NCOR1—urinary bladder cancer	0.000286	0.00107	CbGpPWpGaD
Abacavir—Oedema—Epirubicin—urinary bladder cancer	0.000282	0.000696	CcSEcCtD
Abacavir—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000282	0.000696	CcSEcCtD
Abacavir—Hypotension—Methotrexate—urinary bladder cancer	0.000282	0.000695	CcSEcCtD
Abacavir—Infection—Epirubicin—urinary bladder cancer	0.00028	0.000691	CcSEcCtD
Abacavir—Cough—Doxorubicin—urinary bladder cancer	0.000279	0.000688	CcSEcCtD
Abacavir—Convulsion—Doxorubicin—urinary bladder cancer	0.000277	0.000683	CcSEcCtD
Abacavir—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000277	0.000682	CcSEcCtD
Abacavir—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000276	0.000681	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000275	0.000677	CcSEcCtD
Abacavir—ADK—Metabolism—GPX1—urinary bladder cancer	0.000274	0.00103	CbGpPWpGaD
Abacavir—Skin disorder—Epirubicin—urinary bladder cancer	0.000274	0.000676	CcSEcCtD
Abacavir—Insomnia—Methotrexate—urinary bladder cancer	0.000273	0.000672	CcSEcCtD
Abacavir—Myalgia—Doxorubicin—urinary bladder cancer	0.000272	0.000672	CcSEcCtD
Abacavir—Arthralgia—Doxorubicin—urinary bladder cancer	0.000272	0.000672	CcSEcCtD
Abacavir—Anxiety—Doxorubicin—urinary bladder cancer	0.000271	0.000669	CcSEcCtD
Abacavir—Paraesthesia—Methotrexate—urinary bladder cancer	0.000271	0.000668	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000271	0.000667	CcSEcCtD
Abacavir—ADK—Metabolism—ERCC2—urinary bladder cancer	0.000269	0.00101	CbGpPWpGaD
Abacavir—Discomfort—Doxorubicin—urinary bladder cancer	0.000269	0.000663	CcSEcCtD
Abacavir—Anorexia—Epirubicin—urinary bladder cancer	0.000269	0.000663	CcSEcCtD
Abacavir—Dyspnoea—Methotrexate—urinary bladder cancer	0.000269	0.000663	CcSEcCtD
Abacavir—Hypotension—Epirubicin—urinary bladder cancer	0.000264	0.00065	CcSEcCtD
Abacavir—ADH6—Metabolism—PTEN—urinary bladder cancer	0.000264	0.000986	CbGpPWpGaD
Abacavir—Decreased appetite—Methotrexate—urinary bladder cancer	0.000262	0.000646	CcSEcCtD
Abacavir—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000261	0.000644	CcSEcCtD
Abacavir—Oedema—Doxorubicin—urinary bladder cancer	0.000261	0.000644	CcSEcCtD
Abacavir—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00026	0.000642	CcSEcCtD
Abacavir—Fatigue—Methotrexate—urinary bladder cancer	0.00026	0.000641	CcSEcCtD
Abacavir—Infection—Doxorubicin—urinary bladder cancer	0.000259	0.00064	CcSEcCtD
Abacavir—Pain—Methotrexate—urinary bladder cancer	0.000258	0.000636	CcSEcCtD
Abacavir—UGT1A1—Metabolism—CYP4B1—urinary bladder cancer	0.000258	0.000964	CbGpPWpGaD
Abacavir—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000257	0.000634	CcSEcCtD
Abacavir—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000256	0.000631	CcSEcCtD
Abacavir—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000256	0.00063	CcSEcCtD
Abacavir—Insomnia—Epirubicin—urinary bladder cancer	0.000255	0.000629	CcSEcCtD
Abacavir—Skin disorder—Doxorubicin—urinary bladder cancer	0.000254	0.000625	CcSEcCtD
Abacavir—Paraesthesia—Epirubicin—urinary bladder cancer	0.000253	0.000625	CcSEcCtD
Abacavir—ADK—Metabolism—MTHFR—urinary bladder cancer	0.000253	0.000946	CbGpPWpGaD
Abacavir—Dyspnoea—Epirubicin—urinary bladder cancer	0.000252	0.00062	CcSEcCtD
Abacavir—ADH6—Metabolism—EP300—urinary bladder cancer	0.000251	0.00094	CbGpPWpGaD
Abacavir—Anorexia—Doxorubicin—urinary bladder cancer	0.000249	0.000614	CcSEcCtD
Abacavir—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000249	0.000613	CcSEcCtD
Abacavir—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000247	0.000608	CcSEcCtD
Abacavir—Decreased appetite—Epirubicin—urinary bladder cancer	0.000245	0.000605	CcSEcCtD
Abacavir—Hypotension—Doxorubicin—urinary bladder cancer	0.000244	0.000602	CcSEcCtD
Abacavir—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000244	0.000601	CcSEcCtD
Abacavir—UGT1A1—Metabolism—SLC19A1—urinary bladder cancer	0.000243	0.00091	CbGpPWpGaD
Abacavir—Fatigue—Epirubicin—urinary bladder cancer	0.000243	0.0006	CcSEcCtD
Abacavir—Pain—Epirubicin—urinary bladder cancer	0.000241	0.000595	CcSEcCtD
Abacavir—Urticaria—Methotrexate—urinary bladder cancer	0.00024	0.000591	CcSEcCtD
Abacavir—Abdominal pain—Methotrexate—urinary bladder cancer	0.000238	0.000588	CcSEcCtD
Abacavir—Body temperature increased—Methotrexate—urinary bladder cancer	0.000238	0.000588	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000238	0.000587	CcSEcCtD
Abacavir—UGT1A1—Metabolism—PRSS3—urinary bladder cancer	0.000237	0.000887	CbGpPWpGaD
Abacavir—Insomnia—Doxorubicin—urinary bladder cancer	0.000236	0.000582	CcSEcCtD
Abacavir—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000234	0.000578	CcSEcCtD
Abacavir—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000233	0.000574	CcSEcCtD
Abacavir—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000233	0.000573	CcSEcCtD
Abacavir—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000231	0.000569	CcSEcCtD
Abacavir—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000227	0.00056	CcSEcCtD
Abacavir—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000225	0.000556	CcSEcCtD
Abacavir—Fatigue—Doxorubicin—urinary bladder cancer	0.000225	0.000555	CcSEcCtD
Abacavir—Urticaria—Epirubicin—urinary bladder cancer	0.000224	0.000553	CcSEcCtD
Abacavir—Pain—Doxorubicin—urinary bladder cancer	0.000223	0.00055	CcSEcCtD
Abacavir—Body temperature increased—Epirubicin—urinary bladder cancer	0.000223	0.00055	CcSEcCtD
Abacavir—Abdominal pain—Epirubicin—urinary bladder cancer	0.000223	0.00055	CcSEcCtD
Abacavir—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000222	0.000548	CcSEcCtD
Abacavir—Asthenia—Methotrexate—urinary bladder cancer	0.000216	0.000533	CcSEcCtD
Abacavir—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000215	0.00053	CcSEcCtD
Abacavir—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000214	0.000526	CcSEcCtD
Abacavir—Pruritus—Methotrexate—urinary bladder cancer	0.000213	0.000526	CcSEcCtD
Abacavir—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000208	0.000513	CcSEcCtD
Abacavir—Urticaria—Doxorubicin—urinary bladder cancer	0.000207	0.000511	CcSEcCtD
Abacavir—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000206	0.000509	CcSEcCtD
Abacavir—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000206	0.000509	CcSEcCtD
Abacavir—Diarrhoea—Methotrexate—urinary bladder cancer	0.000206	0.000509	CcSEcCtD
Abacavir—ADK—Metabolism—PPARG—urinary bladder cancer	0.000205	0.000767	CbGpPWpGaD
Abacavir—Asthenia—Epirubicin—urinary bladder cancer	0.000202	0.000499	CcSEcCtD
Abacavir—Pruritus—Epirubicin—urinary bladder cancer	0.0002	0.000492	CcSEcCtD
Abacavir—Dizziness—Methotrexate—urinary bladder cancer	0.000199	0.000492	CcSEcCtD
Abacavir—ADK—Metabolism—CREBBP—urinary bladder cancer	0.000197	0.000737	CbGpPWpGaD
Abacavir—Diarrhoea—Epirubicin—urinary bladder cancer	0.000193	0.000476	CcSEcCtD
Abacavir—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000192	0.000474	CcSEcCtD
Abacavir—Vomiting—Methotrexate—urinary bladder cancer	0.000192	0.000473	CcSEcCtD
Abacavir—Rash—Methotrexate—urinary bladder cancer	0.00019	0.000469	CcSEcCtD
Abacavir—Dermatitis—Methotrexate—urinary bladder cancer	0.00019	0.000468	CcSEcCtD
Abacavir—UGT1A1—Metabolism—TYMP—urinary bladder cancer	0.00019	0.000709	CbGpPWpGaD
Abacavir—Headache—Methotrexate—urinary bladder cancer	0.000189	0.000466	CcSEcCtD
Abacavir—Asthenia—Doxorubicin—urinary bladder cancer	0.000187	0.000462	CcSEcCtD
Abacavir—Dizziness—Epirubicin—urinary bladder cancer	0.000187	0.00046	CcSEcCtD
Abacavir—Pruritus—Doxorubicin—urinary bladder cancer	0.000185	0.000455	CcSEcCtD
Abacavir—Vomiting—Epirubicin—urinary bladder cancer	0.000179	0.000442	CcSEcCtD
Abacavir—Nausea—Methotrexate—urinary bladder cancer	0.000179	0.000442	CcSEcCtD
Abacavir—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000179	0.00044	CcSEcCtD
Abacavir—Rash—Epirubicin—urinary bladder cancer	0.000178	0.000439	CcSEcCtD
Abacavir—Dermatitis—Epirubicin—urinary bladder cancer	0.000178	0.000438	CcSEcCtD
Abacavir—Headache—Epirubicin—urinary bladder cancer	0.000177	0.000436	CcSEcCtD
Abacavir—Dizziness—Doxorubicin—urinary bladder cancer	0.000173	0.000426	CcSEcCtD
Abacavir—UGT1A1—Metabolism—NAT2—urinary bladder cancer	0.000172	0.000641	CbGpPWpGaD
Abacavir—Nausea—Epirubicin—urinary bladder cancer	0.000168	0.000413	CcSEcCtD
Abacavir—Vomiting—Doxorubicin—urinary bladder cancer	0.000166	0.000409	CcSEcCtD
Abacavir—Rash—Doxorubicin—urinary bladder cancer	0.000165	0.000406	CcSEcCtD
Abacavir—Dermatitis—Doxorubicin—urinary bladder cancer	0.000164	0.000406	CcSEcCtD
Abacavir—Headache—Doxorubicin—urinary bladder cancer	0.000164	0.000403	CcSEcCtD
Abacavir—ADK—Metabolism—PTGS2—urinary bladder cancer	0.000161	0.000604	CbGpPWpGaD
Abacavir—Nausea—Doxorubicin—urinary bladder cancer	0.000155	0.000382	CcSEcCtD
Abacavir—UGT1A1—Metabolism—RRM2—urinary bladder cancer	0.000148	0.000554	CbGpPWpGaD
Abacavir—ADK—Metabolism—PTEN—urinary bladder cancer	0.000141	0.000526	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—HPGDS—urinary bladder cancer	0.000137	0.000513	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ENO2—urinary bladder cancer	0.000137	0.000513	CbGpPWpGaD
Abacavir—ADK—Metabolism—EP300—urinary bladder cancer	0.000134	0.000502	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTT1—urinary bladder cancer	0.000133	0.000497	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NQO1—urinary bladder cancer	0.000111	0.000413	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTP1—urinary bladder cancer	9.22e-05	0.000345	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—TYMS—urinary bladder cancer	8.57e-05	0.000321	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTM1—urinary bladder cancer	8.47e-05	0.000317	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NCOR1—urinary bladder cancer	8.47e-05	0.000317	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GPX1—urinary bladder cancer	8.11e-05	0.000303	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ERCC2—urinary bladder cancer	7.97e-05	0.000298	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—MTHFR—urinary bladder cancer	7.49e-05	0.00028	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PPARG—urinary bladder cancer	6.07e-05	0.000227	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CREBBP—urinary bladder cancer	5.83e-05	0.000218	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PTGS2—urinary bladder cancer	4.78e-05	0.000179	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PTEN—urinary bladder cancer	4.17e-05	0.000156	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—EP300—urinary bladder cancer	3.97e-05	0.000149	CbGpPWpGaD
